Quest Diagnostics provides hepatitis diagnostic information services, including genotyping, risk stratifying and viral load testing.
Under terms of the multi-year contract, Quest Diagnostics will provide CDC researchers with analytics expertise and access to the company’s national Quest Diagnostics Health Trends database.
“Our partnership with CDC reflects the growing value of data analytics in healthcare to improve decision making, both for population health and in a clinical setting,” said Rick L. Pesano, MD, PhD, vice president, research and development, and medical director, infectious diseases, for Quest Diagnostics. “Transforming data into insights to measure and predict behaviors and outcomes will be increasingly important as the nation’s healthcare system moves to fill gaps in guideline-based care.”
More articles on GI/endoscopy:
Boston Scientific profits down 19%, Cologuard comes to Kentucky, Sovaldi to go generic & more – 6 GI/endoscopy company key notes
Boston Scientific profits slide 19%: 4 things to know
Kaiser Permanente Fresno names Dr. Smita Rouillard hospital physician leader
